Aducanumab Panel Pushes Back On Rosy FDA Outlook, Could Derail A Swift Approval

 
• By Jessica Merrill
  
Freight train accident
FDA's aducanumab advisory committee meeting puts the review off track • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category